3:21-md-02996•In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation
In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation
3:21-md-02996CandJul 14, 2026
Full text
STIPULATION AND [PROPOSED] ORDER CASE NO. 3:21-MD-2996-CRB (SK) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 STEPHEN P. NEW steve@newlawoffice.com STEPHEN NEW & ASSOCIATES 430 Harper Park Drive Beckley, West Virginia 25801 Telephone: (304) 250-6017 Counsel for Plaintiff Cynthia Woolwine JAMES L. BERNARD (pro hac vice) james.bernard@hlc.com HOGAN LOVELLS CADWALADER US LLP 200 Liberty Street New York, NY 10281 Telephone: (212) 504-6000 REBECCA L. TARNEJA (SBN 293461) rtarneja@goodwinlaw.com GOODWIN PROCTER LLP 601 South Figueroa Street, Suite 4100 Los Angeles, CA 90017 Telephone: (213) 426-2500 MARK DAVID McPHERSON (SBN 307951) mmcpherson@goodwinlaw.com GOODWIN PROCTER LLP The New York Times Building 620 Eighth Avenue New York, NY 10018 Telephone: (212) 813-8800 Attorneys for Defendant McKinsey & Company, Inc., United States UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA IN RE: McKINSEY & CO., INC. NATIONAL PRESCRIPTION OPIATE CONSULTANT LITIGATION This document relates to: ALL ACTIONS Case No. 3:21-md-2996-CRB (SK) STIPULATION AND [PROPOSED] ORDER Judge: Hon. Charles R. Breyer Courtroom: 6, 17th Floor Case 3:21-md-02996-CRB Document 949 Filed 07/14/26 Page 1 of 5
1 STIPULATION AND [PROPOSED] ORDER CASE NO. 3:21-MD-2996-CRB(SK) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 STIPULATION Plaintiff Cynthia Woolwine (“Plaintiff”) and Defendant McKinsey & Company, Inc. (“McKinsey”), by and through their undersigned counsel, hereby stipulate and agree as follows: WHEREAS, on September 21, 2021, the Court entered Pretrial Order No. 4: Protective Order, ECF No. 258 (the “Protective Order”), governing the designation and treatment of Confidential Information and Highly Confidential Information in this litigation; WHEREAS, the Protective Order provides that information disclosed through testimony at a deposition may be designated as Confidential Information or Highly Confidential Information by designating the applicable portions of the transcript in accordance with the procedures set forth in the Protective Order; WHEREAS, the Protective Order further provides a procedure for challenging confidentiality designations, including a requirement that the parties meet and confer in good faith regarding any challenged designation before seeking Court intervention; WHEREAS, the parties have met and conferred regarding Plaintiffs’ challenges to certain of McKinsey’s confidentiality designations for deposition testimony; WHEREAS, the parties have been unable to reach agreement regarding certain challenged designations; WHEREAS, the parties believe that an orderly briefing schedule will promote efficiency and avoid piecemeal motion practice concerning any remaining disputed designations; WHEREAS, the parties further agree that McKinsey may file its motion, and any supporting materials containing or reflecting information designated as Confidential Information or Highly Confidential Information, under seal in accordance with the Protective Order, the Federal Rules of Civil Procedure, the Civil Local Rules of this District, and any applicable standing orders, without prejudice to Plaintiffs’ position that some or all of the materials should not remain sealed or confidential; NOW, THEREFORE, the parties stipulate and agree, subject to Court approval, as follows: Case 3:21-md-02996-CRB Document 949 Filed 07/14/26 Page 2 of 5
2 STIPULATION AND [PROPOSED] ORDER CASE NO. 3:21-MD-2996-CRB(SK) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1. McKinsey shall file its motion to retain confidentiality over certain deposition transcript confidentiality designations that McKinsey believes should be maintained no later than July 17, 2026. 2. Plaintiffs shall file any opposition to McKinsey’s motion by August 7, 2026. 3. McKinsey shall file any reply in support of its motion by August 21, 2026. IT IS SO STIPULATED. Dated: July 13, 2026 By: /s/ James L. Bernard JAMES L. BERNARD (pro hac vice) james.bernard@hoganlovells.com HOGAN LOVELLS CADWALADER US LLP 200 Liberty Street New York, NY 10017 Telephone: (212) 504-6000 MARK DAVID McPHERSON (SBN 307951) mmcpherson@goodwinlaw.com GOODWIN PROCTER LLP The New York Times Building 620 Eighth Avenue New York, NY 10018 Telephone: (212) 813-8800 REBECCA L. TARNEJA (SBN 293461) rtarneja@goodwinlaw.com GOODWIN PROCTER LLP 601 South Figueroa Street, Suite 4100 Los Angeles, CA 90017 Telephone: (213) 426-2500 Attorneys for Defendant McKinsey & Company, Inc., United States Case 3:21-md-02996-CRB Document 949 Filed 07/14/26 Page 3 of 5
3 STIPULATION AND [PROPOSED] ORDER CASE NO. 3:21-MD-2996-CRB(SK) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 By: /s/ Stephen P. New STEPHEN P. NEW steve@newlawoffice.com STEPHEN NEW & ASSOCIATES 430 Harper Park Drive Beckley, West Virginia 25801 Telephone: (304) 250-6017 Counsel for Plaintiff Cynthia Woolwine ATTESTATION Pursuant to Civil Local Rule 5-1(i)(3), I hereby attest that all signatories listed, and on whose behalf the filing is submitted, concur in the filing’s content and have authorized the filing. /s/ James L. Bernard JAMES L. BERNARD Case 3:21-md-02996-CRB Document 949 Filed 07/14/26 Page 4 of 5
4 STIPULATION AND [PROPOSED] ORDER CASE NO. 3:21-MD-2996-CRB(SK) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 STIPULATION ORDER Pursuant to stipulation, and for good cause shown, IT IS SO ORDERED. DATED: HON. CHARLES R. BREYER UNITED STATES DISTRICT JUDGE July 14, 2026 Case 3:21-md-02996-CRB Document 949 Filed 07/14/26 Page 5 of 5
Wondering how this text applies to your situation?
Free consultation, no commitment
Describe your situation. Our team will contact you by email about your consultation.
Continue your research in ChatGPT or Claude
Connect Omnilex to search the legal corpus from your AI assistant.